Cathie Wood’s ARK Invest Buys Over 530,000 Shares of Fate Therapeutics

Photo of Chris Lange
By Chris Lange Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Cathie Wood’s ARK Invest Buys Over 530,000 Shares of Fate Therapeutics

© Thinkstock

One of the ARK Invest exchange-traded funds run by ETF star Cathie Wood made a sizable purchase on Wednesday. The fund bought over 530,000 shares of Fate Therapeutics Inc. (NASDAQ: FATE), as the price of this ETF was down over 2% on the day. Note that this fund is up significantly in the past year.

Specifically, ARK Innovation ETF (NYSEARCA: ARKK | ARKK Price Prediction) bought 535,305 shares of Fate Therapeutics. At Wednesday’s closing price, this would have valued this purchase at roughly $46.2 million. Even though this is a small fraction of the total holdings, every little bit counts. The fund is up 60% in the past year.

Here’s a look at the other purchases across the ARK ETFs:

Fund Ticker Company Shares
ARKF PATH UiPath 279,284
ARKG SGFY Signify Health 53,916
ARKG RXRX Recursion Pharmaceuticals 204,752
ARKG RPTX Repare Therapeutics 18,190
ARKG QSI Quantum-Si 359,389
ARKG MASS 908 Devices 47,945
ARKK FATE Fate Therapeutics 535,305
ARKK COIN Coinbase Global 20,165
ARKK TSLA Tesla 110,731
ARKQ PATH UiPath 135,228
ARKW VUZI Vuzix 521,151
ARKW FTCH Farfetch 599,955
ARKX AVAV Aerovironment 23,098
ARKX PATH UiPath 25,645

[nativounit]
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
[recirclink id=909938][wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618